DE102018215551A1 - Verfahren zur Herstellung eines antitumoralen Arenavirus sowie Arenavirusmutanten - Google Patents
Verfahren zur Herstellung eines antitumoralen Arenavirus sowie Arenavirusmutanten Download PDFInfo
- Publication number
- DE102018215551A1 DE102018215551A1 DE102018215551.8A DE102018215551A DE102018215551A1 DE 102018215551 A1 DE102018215551 A1 DE 102018215551A1 DE 102018215551 A DE102018215551 A DE 102018215551A DE 102018215551 A1 DE102018215551 A1 DE 102018215551A1
- Authority
- DE
- Germany
- Prior art keywords
- primary
- cells
- carcinoma
- virus
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/768—Oncolytic viruses not provided for in groups A61K35/761 - A61K35/766
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/10011—Arenaviridae
- C12N2760/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/10011—Arenaviridae
- C12N2760/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/10011—Arenaviridae
- C12N2760/10032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/10011—Arenaviridae
- C12N2760/10051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/10011—Arenaviridae
- C12N2760/10051—Methods of production or purification of viral material
- C12N2760/10052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/10011—Arenaviridae
- C12N2760/10071—Demonstrated in vivo effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (22)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102018215551.8A DE102018215551A1 (de) | 2018-09-12 | 2018-09-12 | Verfahren zur Herstellung eines antitumoralen Arenavirus sowie Arenavirusmutanten |
| EP19782905.4A EP3694868B1 (en) | 2018-09-12 | 2019-09-12 | Method for producing an antitumoral arenavirus as well as arenavirus mutants |
| PCT/EP2019/074307 WO2020053324A1 (en) | 2018-09-12 | 2019-09-12 | Method for producing an antitumoral arenavirus as well as arenavirus mutants |
| SG11202101970UA SG11202101970UA (en) | 2018-09-12 | 2019-09-12 | Method for producing an antitumoral arenavirus as well as arenavirus mutants |
| IL281299A IL281299B2 (en) | 2018-09-12 | 2019-09-12 | Method for creating an arena virus directed against a tumor and for creating mutants of the virus |
| BR112021004451-5A BR112021004451A2 (pt) | 2018-09-12 | 2019-09-12 | método para produção de um arenavírus antitumoral, bem como mutantes de arenavírus |
| MX2021002937A MX2021002937A (es) | 2018-09-12 | 2019-09-12 | Metodo para producir un arenavirus antitumoral asi como mutantes de arenavirus. |
| ES19782905T ES2908854T3 (es) | 2018-09-12 | 2019-09-12 | Método para producir un arenavirus antitumoral así como mutantes de arenavirus |
| US17/275,967 US12129281B2 (en) | 2018-09-12 | 2019-09-12 | Method for producing an antitumoral arenavirus as well as arenavirus mutants |
| EP21205198.1A EP4019533A1 (en) | 2018-09-12 | 2019-09-12 | Method for producing an antitumoral arenavirus as well as arenavirus mutants |
| KR1020217010631A KR20210057782A (ko) | 2018-09-12 | 2019-09-12 | 항종양 아레나바이러스 및 아레나바이러스 돌연변이체의 제조 방법 |
| AU2019340845A AU2019340845B2 (en) | 2018-09-12 | 2019-09-12 | Method for producing an antitumoral arenavirus as well as arenavirus mutants |
| CN201980074560.2A CN112996802B (zh) | 2018-09-12 | 2019-09-12 | 用于制备抗肿瘤沙粒病毒的方法以及沙粒病毒突变体 |
| DK19782905.4T DK3694868T3 (da) | 2018-09-12 | 2019-09-12 | Fremgangsmåde for at fremstille en antitumoral arenavirus såvel som arenavirusmutanter |
| CN202510196120.1A CN120158432A (zh) | 2018-09-12 | 2019-09-12 | 用于制备抗肿瘤沙粒病毒的方法以及沙粒病毒突变体 |
| NZ774584A NZ774584B2 (en) | 2019-09-12 | Method for producing an antitumoral arenavirus as well as arenavirus mutants | |
| CA3111305A CA3111305A1 (en) | 2018-09-12 | 2019-09-12 | Method for producing an antitumoral arenavirus as well as arenavirus mutants |
| JP2021514594A JP7583448B2 (ja) | 2018-09-12 | 2019-09-12 | 抗腫瘍アレナウイルスおよびアレナウイルス変異体を生産するための方法 |
| PH12021550424A PH12021550424A1 (en) | 2018-09-12 | 2021-03-01 | Method for producing an antitumoral arenavirus as well as arenavirus mutants |
| CL2021000592A CL2021000592A1 (es) | 2018-09-12 | 2021-03-10 | Método para producir un arenavirus antitumoral así como mutantes de arenavirus |
| ZA2021/01833A ZA202101833B (en) | 2018-09-12 | 2021-03-18 | Method for producing an antitumoral arenavirus as well as arenavirus mutants |
| US18/927,732 US20250122244A1 (en) | 2018-09-12 | 2024-10-25 | Method for producing an antitumoral arenavirus as well as arenavirus mutants |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102018215551.8A DE102018215551A1 (de) | 2018-09-12 | 2018-09-12 | Verfahren zur Herstellung eines antitumoralen Arenavirus sowie Arenavirusmutanten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE102018215551A1 true DE102018215551A1 (de) | 2020-03-12 |
Family
ID=68138008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE102018215551.8A Withdrawn DE102018215551A1 (de) | 2018-09-12 | 2018-09-12 | Verfahren zur Herstellung eines antitumoralen Arenavirus sowie Arenavirusmutanten |
Country Status (18)
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121022940A (zh) * | 2025-10-30 | 2025-11-28 | 山东第一医科大学(山东省医学科学院) | 一种抑制塔姆德病毒感染的方法及tcp1抑制剂的用途 |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022180203A1 (en) | 2021-02-26 | 2022-09-01 | Abalos Therapeutics Gmbh | New virus particles for therapeutic purposes |
| IL326615A (en) * | 2023-08-31 | 2026-04-01 | Abalos Therapeutics Gmbh | Virus particles with improved entry into tumor cells |
| CN117867030A (zh) * | 2024-01-15 | 2024-04-12 | 苏州健雄职业技术学院 | 小鼠肺癌细胞系cmt167荧光素酶稳转细胞株的构建与应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004034461A1 (de) * | 2004-07-16 | 2006-02-09 | Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus | Gentherapie solider Tumore durch retrovirale, mit Arenavirus-Glykoprotein pseudotypisierte Vektoren |
| WO2016166285A1 (de) * | 2015-04-17 | 2016-10-20 | Lang Karl Sebastian | Arenaviren zur anwendung bei der behandlung und/oder vorbeugung von tumoren sowie verfahren zur herstellung von arenaviren mit (verbesserten) tumorregressiven eigenschaften |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103993012B (zh) | 2007-12-27 | 2023-01-10 | 苏黎士大学 | 复制缺陷型沙粒病毒载体 |
| KR20110074563A (ko) | 2008-09-24 | 2011-06-30 | 메디뮨 엘엘씨 | 바이러스의 정제 방법 |
| CN102439146A (zh) | 2009-03-23 | 2012-05-02 | 巴斯德研究院 | 适合将免疫原性分子递送到细胞中的突变CyaA多肽及多肽衍生物 |
| WO2012093340A2 (en) * | 2011-01-07 | 2012-07-12 | Bioscience Slovakia | Viral diagnostics |
| JP6162818B2 (ja) * | 2012-12-12 | 2017-07-12 | チルドレンズ ホスピタル オブ イースタン オンタリオ リサーチ インスティチュート インコーポレイテッド | 脳癌の治療のための組成物及び方法 |
| AU2016251687C1 (en) | 2015-04-22 | 2023-07-27 | CureVac SE | RNA containing composition for treatment of tumor diseases |
| CN110167586B (zh) * | 2016-11-04 | 2024-01-30 | 霍欧奇帕生物科技有限公司 | 作为癌症疫苗的复制-缺陷型沙粒病毒颗粒和三-节段沙粒病毒颗粒 |
-
2018
- 2018-09-12 DE DE102018215551.8A patent/DE102018215551A1/de not_active Withdrawn
-
2019
- 2019-09-12 AU AU2019340845A patent/AU2019340845B2/en active Active
- 2019-09-12 EP EP21205198.1A patent/EP4019533A1/en active Pending
- 2019-09-12 IL IL281299A patent/IL281299B2/en unknown
- 2019-09-12 US US17/275,967 patent/US12129281B2/en active Active
- 2019-09-12 JP JP2021514594A patent/JP7583448B2/ja active Active
- 2019-09-12 EP EP19782905.4A patent/EP3694868B1/en active Active
- 2019-09-12 WO PCT/EP2019/074307 patent/WO2020053324A1/en not_active Ceased
- 2019-09-12 CN CN202510196120.1A patent/CN120158432A/zh active Pending
- 2019-09-12 MX MX2021002937A patent/MX2021002937A/es unknown
- 2019-09-12 KR KR1020217010631A patent/KR20210057782A/ko active Pending
- 2019-09-12 CN CN201980074560.2A patent/CN112996802B/zh active Active
- 2019-09-12 BR BR112021004451-5A patent/BR112021004451A2/pt unknown
- 2019-09-12 CA CA3111305A patent/CA3111305A1/en active Pending
- 2019-09-12 SG SG11202101970UA patent/SG11202101970UA/en unknown
- 2019-09-12 DK DK19782905.4T patent/DK3694868T3/da active
- 2019-09-12 ES ES19782905T patent/ES2908854T3/es active Active
-
2021
- 2021-03-01 PH PH12021550424A patent/PH12021550424A1/en unknown
- 2021-03-10 CL CL2021000592A patent/CL2021000592A1/es unknown
- 2021-03-18 ZA ZA2021/01833A patent/ZA202101833B/en unknown
-
2024
- 2024-10-25 US US18/927,732 patent/US20250122244A1/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004034461A1 (de) * | 2004-07-16 | 2006-02-09 | Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus | Gentherapie solider Tumore durch retrovirale, mit Arenavirus-Glykoprotein pseudotypisierte Vektoren |
| WO2016166285A1 (de) * | 2015-04-17 | 2016-10-20 | Lang Karl Sebastian | Arenaviren zur anwendung bei der behandlung und/oder vorbeugung von tumoren sowie verfahren zur herstellung von arenaviren mit (verbesserten) tumorregressiven eigenschaften |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121022940A (zh) * | 2025-10-30 | 2025-11-28 | 山东第一医科大学(山东省医学科学院) | 一种抑制塔姆德病毒感染的方法及tcp1抑制剂的用途 |
Also Published As
| Publication number | Publication date |
|---|---|
| MX2021002937A (es) | 2021-07-16 |
| ZA202101833B (en) | 2022-10-26 |
| SG11202101970UA (en) | 2021-03-30 |
| WO2020053324A1 (en) | 2020-03-19 |
| EP3694868A1 (en) | 2020-08-19 |
| ES2908854T3 (es) | 2022-05-04 |
| US12129281B2 (en) | 2024-10-29 |
| JP7583448B2 (ja) | 2024-11-14 |
| EP3694868B1 (en) | 2021-11-03 |
| NZ774584A (en) | 2024-09-27 |
| IL281299B2 (en) | 2025-07-01 |
| CN112996802A (zh) | 2021-06-18 |
| CN120158432A (zh) | 2025-06-17 |
| IL281299B1 (en) | 2025-03-01 |
| US20250122244A1 (en) | 2025-04-17 |
| EP4019533A1 (en) | 2022-06-29 |
| CN112996802B (zh) | 2025-03-11 |
| CL2021000592A1 (es) | 2021-09-10 |
| KR20210057782A (ko) | 2021-05-21 |
| US20220033445A1 (en) | 2022-02-03 |
| JP2022500054A (ja) | 2022-01-04 |
| IL281299A (en) | 2021-04-29 |
| AU2019340845B2 (en) | 2026-01-29 |
| CA3111305A1 (en) | 2020-03-19 |
| BR112021004451A2 (pt) | 2021-06-01 |
| PH12021550424A1 (en) | 2021-09-20 |
| DK3694868T3 (da) | 2022-02-07 |
| AU2019340845A1 (en) | 2021-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7023929B2 (ja) | キメラポックスウイルス組成物及びその使用 | |
| DE69634904T2 (de) | Negativstrand rna virus mit selbständiger replikationsaktivität | |
| SG10202107138TA (en) | Oncolytic viral vectors and uses thereof | |
| US20250122244A1 (en) | Method for producing an antitumoral arenavirus as well as arenavirus mutants | |
| EP3283104B1 (de) | Arenaviren zur anwendung bei der behandlung eines tumors beim menschen | |
| CN107083385A (zh) | 产热的miRNA调节剂 | |
| US20200206314A1 (en) | Hsv vectors for delivery of nt3 and treatment of cipn | |
| US20250340904A1 (en) | Compositions and therapeutic methods of microrna gene delivery | |
| KR20170103697A (ko) | 엑소좀 또는 엑소좀 유래 리보핵산을 포함하는 간섬유증 예방 또는 치료용 조성물 | |
| CA3109740A1 (en) | Blood-brain barrier permeable aptamer and application thereof | |
| US11524047B2 (en) | Pharmaceutical compositions for preventing or treating pulmonary metastasis of cancer including CHI3L1 inhibitor as active ingredient | |
| EP2978402B1 (de) | Stabilisiertes polyribonucleotid codierend für ein elastisches faserprotein | |
| DE202022003066U1 (de) | Genetische Modifikation von Säugerzellen zur Verleihung von Resistent gegen CSF1R-Antagonisten | |
| US10335481B2 (en) | Gene-modified measles virus for tumor treatment use | |
| DE112018002302T5 (de) | Chimärer Antigenrezeptor von Anti-Human-CD19-Antigen und dessen Anwendung | |
| JP2023549674A (ja) | 癌の処置用の免疫調節治療薬としての免疫細胞におけるsrc-3の標的化 | |
| DE60036929T2 (de) | Gentherapeutika | |
| RU2812046C2 (ru) | Способ продуцирования аренавируса, а также мутантов аренавируса с противоопухолевыми свойствами | |
| US9546354B2 (en) | Z cells activated by zinc finger-like protein and uses thereof in cancer treatment | |
| WO2023230523A1 (en) | Modulation of satellite cell polarity and asymmetric cell division | |
| HUT50636A (en) | Process for influencing cell-relations resistant to lymphokines by applying double-filament rna-s |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R082 | Change of representative |
Representative=s name: SCHIWECK WEINZIERL KOCH PATENTANWAELTE PARTNER, DE |
|
| R163 | Identified publications notified | ||
| R081 | Change of applicant/patentee |
Owner name: ABALOS THERAPEUTICS GMBH, DE Free format text: FORMER OWNER: LANG, KARL SEBASTIAN, PROF. DR., 45149 ESSEN, DE |
|
| R082 | Change of representative |
Representative=s name: SCHIWECK WEINZIERL KOCH PATENTANWAELTE PARTNER, DE |
|
| R081 | Change of applicant/patentee |
Owner name: ABALOS THERAPEUTICS GMBH, DE Free format text: FORMER OWNER: VIROLUTIONS BIOTECH GMBH, 45130 ESSEN, DE |
|
| R005 | Application deemed withdrawn due to failure to request examination |